Skip to main content
Toggle navigation
Search
Home
Back
Like
Facebook
Tweet
Print
Session 17: HER2-Positive Metastatic Breast Cancer: Where are We Headed?
Friday, November 3, 2023
11:30 AM – 12:05 PM
ET
Presenter(s)
Sara Hurvitz, MD
University of California, Los Angeles
Los Angeles, California
Learning Objectives:
Describe the characteristics and prognostic impact of HER2-positive Metastatic Breast Cancer
Identify emerging therapies in early and advanced HER2-positive Metastatic Breast Cancer along with key updates to clinical data
Summarize adverse effects (AEs) expected for current and emerging therapies in HER2-positive breast cancer